Expression of fibrillin-1 in congenital bicuspid aortic valves

National Medical Journal of China

Volumn 87, Issue 22, 2007, Pages 1549-1552

  Huang, Ping ^a   Wang, Hong Wei ^b   Li, Yan Ping ^b   Cheng, Pei Xuan ^b   Zhang, Zhen Lu ^b   Hu, Xiu Fen ^b   Liu, Neng Bao ^b   Li, Xiao Heng ^b   Zhu, Shao Hua ^b   Zheng, Na ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b NONE

Author keywords

Aortic valve; Fibrin; Heart defects, congenital

Indexed keywords

EOSIN; FIBRILLIN 1; HEMATOXYLIN;

ACCIDENTAL DEATH; ADOLESCENT; ADULT; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; AUTOPSY; CHILD; CLINICAL ARTICLE; CONGENITAL BICUSPID AORTIC VALVE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOGENESIS; PROTEIN EXPRESSION; RHEUMATIC HEART DISEASE; STATISTICAL SIGNIFICANCE; TRICUSPID VALVE DISEASE;

ADOLESCENT; AORTIC VALVE; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; MICROFILAMENT PROTEINS;

EID: 34548208678     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Fedak PW, de Sa M, Verma S, et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg, 2003, 126: 797-806.
2. LeMaire SA, Wang X, Wilks JA, et al. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J Surg Res, 2005, 123:40-48.
3. Schoen FJ. Cardiac valves and valvular pathology: update on function, disease, repair, and replacement. Cardiovasc Pathol, 2005, 14:189-194.
4. Fedak PW, Verma S, David TE, et al. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation, 2002, 106:900-904.
5. Burke RD, Wang D, Mark S. Distribution of fibrillin 1 in extracellular matrix and epithelia during early development of avian embryos. Anat Embryol, 2000, 201:317-326.
6. Hurle JM, Kitten GT, Sakai T, et al. Elastic extracellular matrix of the embryonic chick heart: an immunohistological study using laser confocal microscopy. Dev Dyn, 1994, 200:321-332.
7. Bunton TE, Biery NJ, Myers L, et al. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res, 2001, 88:37-43.
8. Cotrufo M, Della Corte A, De Santo LS, et al. Different patterns of extracellular matrix protein expression in the convexity and concavity of the dilated aorta with bicuspid aortic valve: preliminary results. J Thorac Cardiovasc Surg, 2005, 130: 504-511.
9. Segura AM, Luna RE, Horiba K, et al. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysm and aortic valves of patients with Marfan syndrome. Circulation, 1998,98: II331-338.
10. Fondard O, Detaint D, Lung B, et al. Extracellular matrix remodellling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors. Eur Heart J, 2005, 26:1333-1341.
11. Lewin MB, Otto CM. The bicuspid aortic valve: adverse outcomes from infancy to old age. Circulation, 2005, 111:832-834.
12. Eisenberg LM, Markwald RR. Molecular regulation of atriovenntricular valvuloseptal morphogenesis. Circ Res, 1995, 77:1-6.
13. Ashworth IL, Murphy G, Rock MJ. Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodeling. Biochem J, 1999, 340:171-181.
14. Booms P, Pregla R, Ney A, et al. RGD-containing fibrillin-1 fragment upregulate matrix metalloproteinase expression in cell culture: a potential factor in the pathogenesis of the Marfan syndrome. Hum Genet, 2005, 116:51-56.
15. Boyum J, Fellinger EK, Schmoker JD, et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg, 2004, 127:686-691.